The association between depressive symptom severity and metabolic disturbances in major depressive and bipolar disorders: A systematic review and meta-analysis

This publication has 71 references indexed in Scilit:

• Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder
  Pharmacological Reports, 2024
• Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders
  JAMA Network Open, 2024
• Associations between individual depressive symptoms and immunometabolic characteristics in major depression
  European Neuropsychopharmacology, 2023
• Prevalence, risk factors and clinical correlates of glucose disturbances in a large sample of Han Chinese patients with first-episode drug-naïve major depressive disorder
  European Archives of Psychiatry and Clinical Neuroscience, 2023
• Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder
  Journal of Affective Disorders, 2021
• The association of body mass index (BMI) with treatment outcomes in patients with major depressive disorder
  Journal of Affective Disorders, 2021
• Glucose homeostasis in major depression and schizophrenia: a comparison among drug-naïve first-episode patients
  European Archives of Psychiatry and Clinical Neuroscience, 2018
• The metabolic syndrome and related characteristics in major depression: inpatients and outpatients compared
  General Hospital Psychiatry, 2014
• The change of insulin levels after six weeks antidepressant use in drug-naïve major depressive patients
  Journal of Affective Disorders, 2013
• Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
  Archives of General Psychiatry, 2011